Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
RENEW is the planned monotherapy Phase 3 program
With decades of experience treating complex cases and a multidisciplinary team of providers, PMC has the clinical infrastructure to use peptide therapy where it will make the most difference for your specific situation
Storage: Store unreconstituted vials at 28C
Cerebrolysin's modest but replicated clinical effects represent more actionable scientific knowledge than Dihexa's dramatic but unconfirmed preclinical claims
US$ 22.73
US$ 29.06
US$ 28.64
US$ 21.10
US$ 22.68
US$ 27.04
